The guanylate cyclase C—cGMP signaling axis opposes intestinal epithelial injury and neoplasia

JA Rappaport, SA Waldman - Frontiers in oncology, 2018 - frontiersin.org
Guanylate cyclase C (GUCY2C) is a transmembrane receptor expressed on the luminal
aspect of the intestinal epithelium. Its ligands include bacterial heat-stable enterotoxins …

[HTML][HTML] Gastrointestinal ultrasound in functional disorders of the gastrointestinal tract-EFSUMB consensus statement

G Maconi, T Hausken, CF Dietrich… - Ultrasound …, 2021 - thieme-connect.com
Abdominal ultrasonography and intestinal ultrasonography are widely used as first
diagnostic tools for investigating patients with abdominal symptoms, mainly for excluding …

Gut-associated cGMP mediates colitis and dysbiosis in a mouse model of an activating mutation in GUCY2C

V Mishra, A Bose, S Kiran, S Banerjee… - Journal of Experimental …, 2021 - rupress.org
Activating mutations in receptor guanylyl cyclase C (GC-C), the target of gastrointestinal
peptide hormones guanylin and uroguanylin, and bacterial heat-stable enterotoxins cause …

Ultrasound imaging for assessing functions of the GI tract

EK Steinsvik, JG Hatlebakk, T Hausken… - Physiological …, 2021 - iopscience.iop.org
Objective. In the following review we outline how ultrasound can be used to measure
physiological processes in the gastrointestinal tract. Approach. We have investigated the …

[PDF][PDF] Guanylin and uroguanylin: a promising nexus in intestinal electrolyte and fluid homeostasis.

S Samanta, AG Chaudhuri - Journal of Physiology & Pharmacology, 2021 - jpp.krakow.pl
Intestinal guanyl peptides like guanylin and uroguanylin are the potent regulators of fluid-ion
homeostasis. They are secreted from various cells of the intestinal mucosa, including …

Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation

HL von Volkmann, I Brønstad, OH Gilja, R R. Tronstad… - PLoS …, 2017 - journals.plos.org
Introduction Increased intestinal hydration by activation of the epithelial enzyme linked
receptor guanylate cyclase C (GC-C) is a pharmacological principle for treating constipation …

An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer

JA Rappaport, SA Waldman - Expert review of clinical …, 2020 - Taylor & Francis
Introduction: Colorectal cancer remains the second leading cause of cancer death in the
United States, underscoring the need for novel therapies. Despite the successes of new …

Guanylate cyclase C activation shapes the intestinal microbiota in patients with familial diarrhea and increased susceptibility for Crohn's disease

RR Tronstad, M Kummen, K Holm… - Inflammatory Bowel …, 2017 - academic.oup.com
Background With 25% prevalence of Crohn's disease, Familial GUCY2C diarrhea syndrome
(FGDS) is a monogenic disorder potentially suited to study initiating factors in inflammatory …

Clinical course and therapeutic trial for a case of congenital secretory diarrhea due to novel GUCY2C variant

W Scott, IGY Wong, J Cramer, D Horton… - American Journal of …, 2024 - Wiley Online Library
Chronic diarrhea presents a significant challenge for managing nutritional and electrolyte
deficiencies, especially in children, given the higher stakes of impacting growth and …

Plasma levels of guanylins are reduced in patients with Crohn's disease

HL von Volkmann, I Brønstad, RR Tronstad… - Scandinavian Journal …, 2020 - Taylor & Francis
Background: Guanylin (GN) and uroguanylin (UGN) are endogenous ligands for the
intestinal receptor guanylate cyclase C (GC-C), an important regulator of intestinal fluid …